cilostazol Tablets 50 mg, 100 mg

Dossier type
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
Unavailable markets
Saudi Arabia , Vietnam
Manufacturer #358
A pharmaceutical manufacturer based in the EU that is active in 70+ countries worldwide selling its products in the EU, Australia, Pacific region, and Asia for 30+ years. The company owns several manufacturing plants that comply with EU GMP requirements with production facilities for Rx products, OTC products, nutraceuticals, and medical devices. Its key therapy areas are diabetology, oncology, and neuropsychiatry. The company possesses several R&D centers with hundreds of patents and provides e-CTD format dossiers.

Manufacturer usually replies in 23 days

Cilostazol is a medication used to treat intermittent claudication in peripheral vascular disease. Suppliers of cilostazol market it in the form of 50mg and 100mg tablets. The drug was first introduced into the pharmaceutical market in 1999 and has since then become a widely prescribed medication with over a million prescriptions of cilostazol registered yearly in the U.S. alone. The largest manufacturers of cilostazol globally include GlaxoSmithKline, Bristol-Myers Squibb, Bedford Laboratories, Takeda, Novartis, Mylan, Abbot, and Pfizer. Cilostazol suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified cilostazol manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail prices per 56 (100mg) tablets of cilostazol fall into an approximate range of 15,00 EUR to 20,00 EUR.